MSTO1-related disease due to one novel and one reported compound heterozygous MSTO1 variants: a case report and literature review
Frontiers in Genetics · 19.11.2026 · 17
DOI: 10.3389/fgene.2026.1914871 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Genetics, online erschienen am 19.11.2026. Verfasst von Yi Zhou und 5 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
MSTO1 -related disease (previously termed mitochondrial myopathy with ataxia, MMYAT) is a rare autosomal recessive neurometabolic disorder caused by biallelic pathogenic MSTO1 variants. MSTO1 dysfunction impairs mitochondrial dynamics, leading to skeletal muscle lesions and variable cerebellar involvement. Diagnosis is often delayed due to its rarity and phenotypic heterogeneity. Case Presentation We report an 8-year-old male child presenting with progressive motor impairment and ataxia as the core manifestations, accompanied by bulbar dysfunction. The disease had insidious onset with a slowly progressive clinical course over 6 years. Physical examination revealed decreased limb muscle strength. Brain MRI demonstrated cerebellar atrophy and muscle MRI showed prominent fatty replacement in the bilateral quadriceps and hamstrings. Electromyography revealed myopathic changes. Gene sequencing identified compound heterozygous variants in MSTO1 : NM_018116.3:c.36G>T (p (Gln12His), novel) and NM_018116.3:c.971C>T (p (Thr324Ile), previously reported). Parental Sanger sequencing confirmed that the two variants were located in trans . During follow-up, the patient received empirical supportive medical management.
Conclusion
We describe a pediatric case of MSTO1 -related disease carrying compound heterozygous variants and summarize the clinical, neuroimaging and genetic characteristics of published MSTO1 -related patients. Clinicians should raise awareness of this rare disorder among children with progressive movement disorders and cerebellar atrophy, to achieve timely diagnosis and optimized supportive care.
Zitieren
APA
Zhou, Y., Li, Y., Li, G., Niu, Y., Jiao, S., & Li, C. (2026). MSTO1-related disease due to one novel and one reported compound heterozygous MSTO1 variants: a case report and literature review. Frontiers in Genetics, 17. https://doi.org/10.3389/fgene.2026.1914871
Vancouver
Zhou Y, Li Y, Li G, Niu Y, Jiao S, Li C. MSTO1-related disease due to one novel and one reported compound heterozygous MSTO1 variants: a case report and literature review. Frontiers in Genetics. 2026;17. doi:10.3389/fgene.2026.1914871
BibTeX
@article{Zhou2026,
author = {Zhou, Yi and Li, Yan and Li, Gang and Niu, Yunfeng and Jiao, Shusheng and Li, Chongling},
title = {MSTO1-related disease due to one novel and one reported compound heterozygous MSTO1 variants: a case report and literature review},
journal = {Frontiers in Genetics},
year = {2026},
volume = {17},
doi = {10.3389/fgene.2026.1914871}
}
EUVIMED